What is Sastasundar Ventures Ltd's market cap?

Sastasundar Ventures Ltd (SASTASUNDR) has a market capitalization of ₹875 Cr.

What sector is SASTASUNDR in?

Sastasundar Ventures Ltd operates in the Healthcare — Hospitals & Diagnostics sector.

What is SASTASUNDR's return on equity?

Sastasundar Ventures Ltd has a return on equity (ROE) of 3.8%.

Loading company...

Analyzing...

Sastasundar Ventures Ltd (SASTASUNDR) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Sastasundar Ventures Ltd

SASTASUNDR|BSE: 533259

Healthcare — Hospitals & DiagnosticsHealthcare & Life Scienceswww.sastasundarventures.com

—

—|MCap ₹875 Cr

Promoter: 74.8%

PE 171.0xMedian PE 35.4xPB 2.9x

Sastasundar Ventures Ltd. distributes health care and pharmaceutical products. The company is headquartered in Kolkata, West Bengal. The company went IPO on 2010-10-05. The firm's segments include Fin

Secular Currents

Theme Connections

Healthcare Access Wealth Management Insurance Penetration Fintech Penetration

Intelligence Profile

TSF Score

64/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

15Clean

Trust Score

X-Ray

Concerns

🟠Below-average return on equity (3.8%)Business

Watch

Nothing flagged for monitoring

Strengths

🟢Healthy revenue growth (22.1% CAGR 3yr)Business
🟢Low leverage (D/E: 0.00x)Business

The Numbers · Key Metrics

PE Ratio

171.0x

ROE

3.8%

Revenue Growth 3yr

22.1%

Debt/Equity

0.00x

₹863 Cr

The Narrator · StoryTel Intelligence

FY2025Healthcare — Hospitals & DiagnosticsProduct Sales ModelModel:Revenue = Number of Patients × Average Revenue per Patient (ARPOB for hospitals; Revenue per Test for diagnostics)

Key Insight

“Services business in Healthcare — Hospitals & Diagnostics.”

The Revenue Story

₹1,111 Cr service revenue.

Total Income₹1,171 Cr

Revenue₹1,111 Cr(94.9% of Total Income)

Other Income₹60 Cr(5.1% of Total Income)

The Cost Story

Employee costs at 4.5% of revenue — primary cost driver.

EBITDA₹960 Cr(85.9%)

Other Expenses₹100 Cr(8.9%)

Employee₹50 Cr(4.5%)

Depreciation₹6 Cr(0.5%)

Subcontracting₹2 Cr(0.2%)

Finance Costs₹0.22 Cr(0.0%)

0.0%EBITDA Margin

EBITDA

85.9%

Other Expenses

8.9%

Employee

4.5%

Depreciation

0.5%

Subcontracting

0.2%

Finance Costs

0.0%

Key Metrics

ROE

3.8%

vs median 7.9%

ROCE

0.9%

vs median 11.3%

Net Margin

2.0%

vs median 9.3%

EBITDA Margin

1.1%

vs median 21.9%

Debt To Equity

0.00x

vs median 0.16x

Rev Growth 3yr

22.1%

vs median 12.4%

Employee Cost Ratio

4.50x

Forward View · Management Guidance

GUIDANCEQ2FY26— 2High Impact

“By 2930, we are working for revenue of 6,000 crores, 4,000 in Retailer and around 2,000 in B2C. This will generate around 4 to 5% EBITDA”

GUIDANCEQ2FY26— 2High Impact

“I'm targeting the last quarter of next year. So in '26 last quarter, it would be able to close at 500 crore”

GUIDANCEQ2FY26— 0High Impact

“Targeting 4,000 crore number in Whitivar Shakti by FY30”

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Healthcare — Hospitals & Diagnostics

KPI	Company	Sector Median
ROE	3.8%▼	7.9%
ROCE	0.9%▼	11.3%
Net Margin	2.0%▼	9.3%
EBITDA Margin	1.1%▼	21.9%
Debt To Equity	0.00x▼	0.16x
Rev Growth 3yr	22.1%▲	12.4%
Employee Cost Ratio	4.50x	-

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Low Impact

The Numbers · Show me the data

Financials

Revenue₹1,231 Cr

PBT₹8 Cr

EPS₹8.19

(₹ Cr)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
	₹1,231 Cr +10.8%	₹1,111 Cr -19.2%	₹1,376 Cr +32.3%	₹1,040 Cr +64.7%	₹631 Cr +15.2%	₹548 Cr +42.2%	₹385 Cr +76.4%	₹219 Cr
	₹66 Cr +10.5%	₹60 Cr -0.9%	₹60 Cr +155.6%	₹24 Cr +103.2%	₹12 Cr +239.3%	₹3 Cr +9.9%	₹3 Cr +29.3%	₹2 Cr
Total Income	₹1,297 Cr +10.8%	₹1,171 Cr -18.5%	₹1,436 Cr +35.0%	₹1,063 Cr +65.4%	₹643 Cr +16.6%	₹552 Cr +42.0%	₹389 Cr +75.9%	₹221 Cr
COGS	₹1,123 Cr +10.4%	₹1,017 Cr -17.5%	₹1,233 Cr +28.4%	₹960 Cr +64.9%	₹582 Cr +18.3%	₹492 Cr +34.2%	₹367 Cr +83.9%	₹199 Cr
	₹1,290 Cr +10.0%	₹1,173 Cr -15.0%	₹1,380 Cr +26.3%	₹1,093 Cr +59.3%	₹686 Cr +20.8%	₹568 Cr +27.2%	₹446 Cr +69.3%	₹264 Cr
Profit Before Tax	₹8 Cr ↑ Recovery	(₹193 Cr) ↓ Decline	₹56 Cr ↑ Recovery	(₹37 Cr) ↓ Decline	₹1,115 Cr ↑ Recovery	(₹16 Cr) +71.6%	(₹58 Cr) -34.9%	(₹43 Cr)
Exceptional Items	₹0.11 Cr ↑ Recovery	(₹191 Cr)	₹0.00 Cr +100.0%	(₹8 Cr) ↓ Decline	₹1,157 Cr	₹0.00 Cr -100.0%	₹0.29 Cr	₹0.00 Cr
	(₹21 Cr) +69.7%	(₹70 Cr) -92.9%	(₹36 Cr) -59.6%	(₹23 Cr) ↓ Decline	₹131 Cr	₹0.73 Cr ↑ Recovery	(₹5 Cr) ↓ Decline	₹1.00 Cr
Net Profit	₹29 Cr ↑ Recovery	(₹134 Cr) ↓ Decline	₹6 Cr ↑ Recovery	(₹99 Cr) ↓ Decline	₹978 Cr ↑ Recovery	(₹17 Cr) +67.2%	(₹52 Cr) -19.3%	(₹44 Cr)
Profit (Owners)	₹26 Cr ↑ Recovery	(₹91 Cr) ↓ Decline	₹9 Cr ↑ Recovery	(₹72 Cr) ↓ Decline	₹709 Cr ↑ Recovery	(₹10 Cr) +73.2%	(₹39 Cr) -1.1%	(₹38 Cr)
Minority Interest	₹3 Cr ↑ Recovery	(₹42 Cr)	(₹3 Cr) +88.9%	(₹27 Cr) ↓ Decline	₹270 Cr ↑ Recovery	(₹7 Cr) +49.8%	(₹13 Cr) -150.3%	(₹5 Cr)
Other Comprehensive Income	(₹0.01 Cr) +98.5%	(₹0.45 Cr) ↓ Decline	₹0.12 Cr ↑ Recovery	(₹1 Cr) -365.1%	(₹0.26 Cr) ↓ Decline	₹0.25 Cr ↑ Recovery	(₹0.24 Cr)	₹0.00 Cr
EPS	₹8.19	(₹28.66)	₹2.79	(₹22.70)	₹222.73	(₹3.27)	(₹12.20)	(₹12.06)
Diluted Shares	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr
Profit Or Loss Of Associates	₹0.00 Cr +100.0%	(₹11 Cr) +87.5%	(₹86 Cr) -1.5%	(₹85 Cr)	(₹5 Cr)	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr